By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Viamet Pharmaceuticals 

406 Blackwell Street
Suite 200
Durham  North Carolina  27701-3984  U.S.A.
Phone: 919-969-7505 Fax: n/a



Start Up

Company News
Viamet Release:FDA Grants QIDP and Fast Track Designations to VT-1161 for Treatment of Recurrent Vulvovaginal Candidiasis 10/12/2016 11:05:37 AM
Viamet To Present At The 25th European Academy Of Dermatology And Venereology Congress 9/27/2016 11:57:04 AM
Viamet To Present At The 2016 Mycoses Study Group Education And Research Consortium (MSGERC) Conference 9/19/2016 12:00:49 PM
Viamet Release: FDA Grants QIDP Designation To VT-1598 For Treatment Of Valley Fever 9/15/2016 1:30:13 PM
Viamet Release: Positive Interim Clinical Results For VT-1161 To Be Presented At The Infectious Diseases Society For Obstetrics And Gynecology Annual Meeting 8/10/2016 11:42:19 AM
Viamet Receives Fast Track Designation From The FDA For VT-1129 For The Treatment Of Cryptococcal Meningitis 6/1/2016 12:01:06 PM
Viamet Receives Orphan Drug Designation From The FDA For VT-1598 For The Treatment Of Coccidioidomycosis 5/25/2016 10:36:33 AM
Viamet Postpones $86 Million IPO 5/12/2016 7:19:23 AM
Backed by Novartis AG (NVS), Viamet Sets Terms for $86 Million IPO 5/4/2016 6:38:31 AM
Viamet Reports Positive Results From Interim Analysis Of REVIVE Phase IIb Trial Of VT-1161 In Recurrent Vulvovaginal Candidiasis 3/9/2016 8:21:54 AM